Anterra Capital

Managing partners Philip Austin and Adam Anders lead the investment team from Amsterdam and Boston. Austin previously built Rabobank's global venture capital activities; Anders was a managing director within the same group. Both sit on multiple portfolio company boards and drive final investment committee decisions.

Anterra's deal flow originates from a network that combines Rabobank's global food and agriculture lending operations, FMO's development finance relationships in emerging markets, and the StartLife incubator at Wageningen University & Research — the top-ranked agricultural university worldwide. This creates visibility into early-stage companies that other venture capital firms rarely see before a commercial round.

Anterra invests directly in companies and does not make fund commitments. Capital is deployed as equity into Seed through Series B rounds, with occasional follow-on investments in later stages. The firm does not operate a fund-of-funds program.

Anterra will not invest in companies that conflict with its impact mandate — including businesses focused on tobacco, factory farming, or synthetic biology applications that harm biodiversity. The firm also avoids generalist software and consumer internet companies that fall outside the food, agriculture, and digital health nexus.

Anterra regularly co-invests alongside corporate venture arms, development finance institutions, and specialist agri-food investors. Recent syndicate partners include BASF Venture Capital, Rabo Food & Agri Innovation Fund, and Astanor Ventures. The firm does not passively follow other VCs; it seeks to co-lead or play an active board role when syndicating.